Arachidonoyl amide Size:Contact [email protected] for quotation CC1C=C(C=C(C)C=1OC1C=C(C(O)C2C=CC(F)=CC=2)C(O)=CC=1)NC(=O)CC(O)=O |^1:0|

CC1C=C(C=C(C)C=1OC1C=C(C(O)C2C=CC(F)=CC=2)C(O)=CC=1)NC(=O)CC(O)=O |^1:0|

InChi: InChI=1S/C15H17ClN2O2S/c16-14-6-1-5-13-12(14)4-2-7-15(13)21(19

Smiles: CN1C(=O)C2=C(N=CN2CCO)N(C)C1=O

RWJ 67657 (10 μM

Smiles: COCCOCCOCCOCCOCCOCCBr

Arachidonoyl amide Size:Contact [email protected] for quotation CC1C=C(C=C(C)C=1OC1C=C(C(O)C2C=CC(F)=CC=2)C(O)=CC=1)NC(=O)CC(O)=O |^1:0|Arachidonoyl amide is a CB1 receptor agonist . The cannabinoid receptor type 1, abbreviated as CB1, is a G protein coupled cannabinoid receptor expressed primarily in the central and peripheral nervous system. CB1 receptor has been implicated in maintaining the homeostasis in health and disease. Overexpression of CB1 receptor has been found in human hepatocellular carcinoma tumor samples and other human prostate cancer cells . Arachidonoyl amide is an